Faculty of Medicine Estácio of Juazeiro do Norte, FMJ, Ceará, Brazil.
Pharmacol Biochem Behav. 2013 Mar;104:144-53. doi: 10.1016/j.pbb.2013.01.002. Epub 2013 Jan 11.
Piperine, an alkaloid present in the Piper genus, was shown to have an anticonvulsant activity, evaluated by the pilocarpine-induced model, in mice. Pilocarpine (350mg/kg, i.p.) was administered 30min after piperine (2.5, 5, 10 and 20mg/kg, i.p.) which significantly increased latencies to 1st convulsion and to death, and percentage of survivals. These parameters were also increased in the pilocarpine groups pretreated with atropine plus piperine (10 and 2.5mg/kg, respectively), as related to the pilocarpine group. However, they were not altered in the pilocarpine groups pretreated with memantine (a NMDA-type glutamate receptors blocker, 2mg/kg, p.o.) or nimodipine (a calcium channel blocker, 10mg/kg, p.o.), both associated with piperine (1 or 2.5mg/kg), as compared to the piperine plus pilocarpine group. Moreover, the pilocarpine group pretreated with diazepam (which binds to the GABAA receptor, 0.2 and 0.5mg/kg, i.p.) plus piperine (1 and 2.5mg/kg) significantly increased latency to the 1st convulsion, as related to the pilocarpine group, suggesting that the GABAergic system is involved with the piperine action. Furthermore, the piperine effect was blocked by flumazenil (2mg/kg, i.p.), a benzodiazepine antagonist. Untreated P350 animals showed decreased striatal DA and increased DOPAC and HVA levels that were not affected in the piperine plus pilocarpine groups. Piperine increased striatal levels of GABA, glycine and taurine, and reversed pilocarpine-induced increases in nitrite contents in sera and brain. Hippocampi from the untreated pilocarpine group showed an increased number of TNF-α immunostained cells in all areas, as opposed to the pilocarpine group pretreated with piperine. Taken together, piperine anticonvulsant effects are the result of its anti-inflammatory and antioxidant actions, as well as TNF-α reduction. In addition, piperine effects on inhibitory amino acids and on the GABAergic system may certainly contribute to the drug anticonvulsant activity.
胡椒碱是胡椒属中的一种生物碱,已被证明具有抗惊厥活性,可通过匹鲁卡品诱导的模型在小鼠中进行评估。在给予胡椒碱(2.5、5、10 和 20mg/kg,ip)后 30 分钟,给予匹鲁卡品(350mg/kg,ip),这显著增加了首次抽搐和死亡的潜伏期,并增加了存活率。与匹鲁卡品组相比,用阿托品加胡椒碱预处理的匹鲁卡品组(分别为 10 和 2.5mg/kg)也增加了这些参数。然而,用美金刚(一种 NMDA 型谷氨酸受体阻滞剂,2mg/kg,po)或尼莫地平(一种钙通道阻滞剂,10mg/kg,po)预处理的匹鲁卡品组并未改变,两者均与胡椒碱(1 或 2.5mg/kg)相关,与胡椒碱加匹鲁卡品组相比。此外,用地西泮(与 GABA A 受体结合,0.2 和 0.5mg/kg,ip)加胡椒碱(1 和 2.5mg/kg)预处理的匹鲁卡品组,首次抽搐的潜伏期显著增加,与匹鲁卡品组相比,表明 GABA 能系统参与了胡椒碱的作用。此外,氟马西尼(2mg/kg,ip),一种苯二氮䓬拮抗剂,阻断了胡椒碱的作用。未经处理的 P350 动物的纹状体 DA 减少,DOPAC 和 HVA 水平增加,而在胡椒碱加匹鲁卡品组中没有受到影响。胡椒碱增加了纹状体 GABA、甘氨酸和牛磺酸的水平,并逆转了匹鲁卡品诱导的血清和脑中亚硝酸盐含量的增加。未经处理的匹鲁卡品组的海马体在所有区域的 TNF-α免疫染色细胞数量增加,而用胡椒碱预处理的匹鲁卡品组则相反。综上所述,胡椒碱的抗惊厥作用是其抗炎和抗氧化作用以及 TNF-α 减少的结果。此外,胡椒碱对抑制性氨基酸和 GABA 能系统的作用肯定有助于药物的抗惊厥活性。